LIFE-U:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund (USD)

ETF | Others |

Last Closing

CAD 21.87

Change

0.00 (0.00)%

Market Cap

N/A

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

N/A

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

-0.01 (-0.01%)

CAD 5.37B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

-0.01 (-0.01%)

CAD 5.37B
XEQT:CA iShares Core Equity Portfolio

+0.01 (+0.03%)

CAD 4.78B
XEQT:CA iShares Core Equity Portfolio

+0.01 (+0.03%)

CAD 4.78B
PHYS-U:CA Sprott Physical Gold Trust

-0.11 (-0.54%)

CAD 4.76B
PHYS-U:CA Sprott Physical Gold Trust

-0.11 (-0.54%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.11 (+0.30%)

CAD 4.54B
XUS-U:CA iShares Core S&P 500 Index ETF

+0.11 (+0.30%)

CAD 4.54B

ETFs Containing LIFE-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.42% 36% F 37% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.42% 35% F 34% F
Trailing 12 Months  
Capital Gain 9.35% 29% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.35% 28% F 29% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -2.00% N/A N/A 24% F
Dividend Return -1.97% N/A N/A 17% F
Total Return 0.03% N/A N/A 5% F
Risk Return Profile  
Volatility (Standard Deviation) 5.82% N/A N/A 91% A-
Risk Adjusted Return -33.88% N/A N/A 12% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike